Literature DB >> 29801126

Delayed Generic Market Saturation After Patent Expiration-A Billion-Dollar Problem.

Jing Luo1, Aaron S Kesselheim1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29801126     DOI： 10.1001/jamainternmed.2018.0989

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  2 in total

1.  Use of budget savings from patent expiration of cancer drugs to improve affordability and accessibility.

Authors:  Seung Mi Lee; Heui Jae Kim; David Suh; Kyung-In Joung; Eun Suk Kim; Hee Jung Back; Jun Young Kwon; Man-Jae Park; Dong Churl Suh
Journal:  BMC Health Serv Res       Date:  2021-02-06       Impact factor: 2.655

2.  Trends in Use and Expenditures for Brand-name Statins After Introduction of Generic Statins in the US, 2002-2018.

Authors:  Shuo-Yu Lin; Kyle Baumann; Chenxuan Zhou; Weiyu Zhou; Alison Evans Cuellar; Hong Xue
Journal:  JAMA Netw Open       Date:  2021-11-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.